Skip to Main Content

Publications

Kuo, M. C., et al. (2019). "Myeloid zinc finger-1 regulates expression of cancer-associated fibroblast and cancer stemness profiles in breast cancer." Surgery 166(4): 515-523.

Kuo, M. C., et al. (2018). "Cancer stemness in bone marrow micrometastases of human breast cancer." Surgery 163(2): 330-335.

Weber, C. E., et al. (2016). "Pancreatic Cancer and Osteopontin: The Relationship Remains Unclear." Pancreas 45(7): e35-36.

Kothari, A. N., et al. (2016). "Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition." J Clin Med 5(4).

Coombes, J. D., et al. (2016). "Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis." Biochim Biophys Acta 1862(1): 135-144.

Arffa, M. L., et al. (2016). "Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis." PLoS ONE 11(12): e0167435.

Driver, J., et al. (2015). "Alcohol inhibits osteopontin-dependent transforming growth factor-β1 expression in human mesenchymal stem cells." J Biol Chem 290(16): 9959-9973.

Zapf, M. A., et al. (2015). "Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma." Surgery 158(4): 1039-1047.